Oculoplastics News

A 52-year-old Latin-American man was referred to the Oculoplastics service at the New England Eye Center for evaluation of presumed pyogenic granuloma. The patient reported a history of a rapidly growing “stye” in his left lower eyelid for the prior 2 weeks. He denied any associated pain, erythema or discharge. Medical history was positive only for diet-controlled diabetes. He denied any history of malignancy or sexually transmitted infections such as HIV. Ocular history was unremarkable, including any history of trauma or surgery to the eyelid. He was not taking any medications. The patient also denied any history of smoking, intravenous drug use or high-risk sexual activity. He worked as a driver.

The FACE-Q Eye Module is a validated patient-reported outcome measure for analyzing patient satisfaction and adverse effects following cosmetic eye treatments, according to study results published in JAMA Facial Plastic Surgery.

The recipient of the most extensive face transplant ever performed is experiencing a successful recovery at the 1-year anniversary of the surgery, according to NYU Langone Medical Center.

At Hawaiian Eye, Wendy W. Lee, MD, discusses the diagnosis and management of benign and malignant eye lid lesions.

At Hawaiian Eye, Jeremiah Tao, MD, FACS, gives a case-based presentation on surgical procedures for areas in the eyelid, lacrimal system and orbit.

At Hawaiian Eye, Andrew R. Harrison, MD, shares pearls on how to perform blepharoplasty and achieve positive aesthetic results and no complications, as well as maintaining patient satisfaction.

At Hawaiian Eye, Steve G. Yoelin, MD, shares pearls for using neuromodulators and toxins in the ophthalmic practice.

At Hawaiian Eye, Roger A. Dailey, MD, FACS, discusses available lights and lasers that ophthalmologists can use in their practice.

At Hawaiian Eye, Joely Kaufman, MD, FAAD, discusses the benefits of incorporating topical medications and peels for minimally invasive cosmetic surgery.

The American Society of Ophthalmic Plastic and Reconstructive Surgery announced in a press release it has named Robert Alan Goldberg, MD, as president.